-
Something wrong with this record ?
Usefulness of Heart Rate Control in Atrial Fibrillation Patients With Obstructive Sleep Apnea
T. Konecny, PA. Brady, JY. Park, PK. Reddy, L. Ruzek, L. Mach, SM. Caples, VK. Somers,
Language English Country United States
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
UL1 TR000135
National Center for Advancing Translational Sciences - United States
NLK
ProQuest Central
from 2012-08-15 to 2 months ago
Nursing & Allied Health Database (ProQuest)
from 2012-08-15 to 2 months ago
Health & Medicine (ProQuest)
from 2012-08-15 to 2 months ago
- MeSH
- Amiodarone therapeutic use MeSH
- Anti-Arrhythmia Agents therapeutic use MeSH
- Adrenergic beta-Antagonists therapeutic use MeSH
- Calcium Channel Blockers therapeutic use MeSH
- Electrocardiography, Ambulatory MeSH
- Atrial Fibrillation drug therapy physiopathology MeSH
- Humans MeSH
- Sleep Apnea, Obstructive physiopathology MeSH
- Polysomnography MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Heart Rate physiology MeSH
- Severity of Illness Index MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
In patients without atrial fibrillation and flutter (AF), obstructive sleep apnea (OSA) is associated with cyclic and often marked changes in heart rate (HR). We aimed to assess whether presence of OSA impacts optimal HR control in patients in AF. We retrospectively correlated diurnal HR patterns (recorded by 24-hour Holter monitoring) in patients with AF who independently also underwent diagnostic polysomnography. Exclusion criteria were paced rhythm or inadequate recordings from polysomnography and Holter monitoring. The relationship between the presence and severity of OSA and the mean, minimum, maximum HR, as well as pauses (>2 seconds) and their diurnal variation were studied. Of the 494 studied patients (age 69 ± 10 years; 26% women) mild-moderate OSA (apnea hypoxia index ≥5 and <20) was present in 171 (34%) and severe OSA (apnea hypoxia index ≥20) in 254 (51%). Mean 24-hour HR in patients with severe OSA and mild-moderate OSA was similar to those without OSA (78 vs 80 vs 79 beats per minute; p = 0.39), and there was no significant difference observed in minimum and maximum HR of these groups. However, the frequency of short pauses was greater in OSA patients (p = 0.009), with a prominent nocturnal distribution. In conclusion, OSA was not associated with increased HR in patients with AF suggesting that adequate HR control was similarly achievable in patients with and without OSA. The increased frequency of nocturnal pauses in OSA patients may function as a clinical hallmark, and the timing of pauses (during sleep vs wakefulness) should be noted before making therapeutic decisions regarding HR control.
Keck School of Medicine University of Southern California Los Angeles California
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035007
- 003
- CZ-PrNML
- 005
- 20191015115105.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.amjcard.2018.07.030 $2 doi
- 035 __
- $a (PubMed)30244846
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Konecny, Tomas $u Keck School of Medicine, University of Southern California, Los Angeles, California. Electronic address: tomas.konecny@med.usc.edu.
- 245 10
- $a Usefulness of Heart Rate Control in Atrial Fibrillation Patients With Obstructive Sleep Apnea / $c T. Konecny, PA. Brady, JY. Park, PK. Reddy, L. Ruzek, L. Mach, SM. Caples, VK. Somers,
- 520 9_
- $a In patients without atrial fibrillation and flutter (AF), obstructive sleep apnea (OSA) is associated with cyclic and often marked changes in heart rate (HR). We aimed to assess whether presence of OSA impacts optimal HR control in patients in AF. We retrospectively correlated diurnal HR patterns (recorded by 24-hour Holter monitoring) in patients with AF who independently also underwent diagnostic polysomnography. Exclusion criteria were paced rhythm or inadequate recordings from polysomnography and Holter monitoring. The relationship between the presence and severity of OSA and the mean, minimum, maximum HR, as well as pauses (>2 seconds) and their diurnal variation were studied. Of the 494 studied patients (age 69 ± 10 years; 26% women) mild-moderate OSA (apnea hypoxia index ≥5 and <20) was present in 171 (34%) and severe OSA (apnea hypoxia index ≥20) in 254 (51%). Mean 24-hour HR in patients with severe OSA and mild-moderate OSA was similar to those without OSA (78 vs 80 vs 79 beats per minute; p = 0.39), and there was no significant difference observed in minimum and maximum HR of these groups. However, the frequency of short pauses was greater in OSA patients (p = 0.009), with a prominent nocturnal distribution. In conclusion, OSA was not associated with increased HR in patients with AF suggesting that adequate HR control was similarly achievable in patients with and without OSA. The increased frequency of nocturnal pauses in OSA patients may function as a clinical hallmark, and the timing of pauses (during sleep vs wakefulness) should be noted before making therapeutic decisions regarding HR control.
- 650 _2
- $a beta blokátory $x terapeutické užití $7 D000319
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a amiodaron $x terapeutické užití $7 D000638
- 650 _2
- $a antiarytmika $x terapeutické užití $7 D000889
- 650 _2
- $a fibrilace síní $x farmakoterapie $x patofyziologie $7 D001281
- 650 _2
- $a blokátory kalciových kanálů $x terapeutické užití $7 D002121
- 650 _2
- $a elektrokardiografie ambulantní $7 D015716
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční frekvence $x fyziologie $7 D006339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a polysomnografie $7 D017286
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a obstrukční spánková apnoe $x patofyziologie $7 D020181
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brady, Peter A $u Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Park, Jae Y $u Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Reddy, Pavan K $u Keck School of Medicine, University of Southern California, Los Angeles, California.
- 700 1_
- $a Ruzek, Lukas $u St. Anne's Hospital - ICRC, Brno, Czech Republic.
- 700 1_
- $a Mach, Lukas $u St. Anne's Hospital - ICRC, Brno, Czech Republic.
- 700 1_
- $a Caples, Sean M $u Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Somers, Virend K $u Mayo Clinic, Rochester, Minnesota.
- 773 0_
- $w MED00000236 $t The American journal of cardiology $x 1879-1913 $g Roč. 122, č. 9 (2018), s. 1482-1488
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30244846 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191015115531 $b ABA008
- 999 __
- $a ok $b bmc $g 1451667 $s 1073557
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 122 $c 9 $d 1482-1488 $e 20180804 $i 1879-1913 $m The American journal of cardiology $n Am J Cardiol $x MED00000236
- GRA __
- $a UL1 TR000135 $p National Center for Advancing Translational Sciences $2 United States
- LZP __
- $a Pubmed-20191007